Energy based Ablation Devices

Energy based Ablation Devices

Global Energy based Ablation Devices Market to Reach US$18.8 Billion by 2030

The global market for Energy based Ablation Devices estimated at US$8.9 Billion in the year 2023, is expected to reach US$18.8 Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2023-2030. Radiation Technology, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.0 Billion by the end of the analysis period. Growth in the Radiofrequency Technology segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 14.6% CAGR

The Energy based Ablation Devices market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 14.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Energy based Ablation Devices Market - Key Trends and Drivers Summarized

Energy-based ablation devices are gaining traction as essential tools in modern medical treatments, employing techniques like cryotherapy, radiofrequency, microwave, and laser ablation to address a variety of conditions including cancers, arrhythmias, and benign tumors. The increasing global prevalence of such diseases, particularly cancer, has driven the demand for these devices, offering a minimally invasive alternative to traditional surgical procedures. Innovations in ablation technology have enhanced the precision and efficiency of these devices, improving their ability to target diseased tissues while minimizing damage to surrounding healthy tissues. This has encouraged broader adoption in clinical settings, as these devices align well with the current healthcare trend towards less invasive treatment options. The growing awareness of the benefits of energy-based ablation treatments, such as reduced recovery times and minimized surgical risks, is further boosting their acceptance and preference over more invasive surgical methods.

The market for energy-based ablation devices is expanding due to several factors, including the rise in chronic diseases that require intervention and the growing acceptance of minimally invasive procedures. These devices, integral to less traumatic medical interventions, align with healthcare preferences for procedures that offer fewer complications and quicker recovery times. Economically, ablation procedures are cost-effective compared to traditional surgeries, often requiring shorter hospital stays or outpatient settings, which reduces healthcare costs significantly. This economic efficiency is driving their adoption by healthcare systems under pressure to reduce expenses while improving patient outcomes. Furthermore, supportive regulatory environments are speeding up the introduction of innovative ablation devices into the market, with governments and regulatory bodies facilitating their adoption through favorable policies.

The expansion of clinical applications for energy-based ablation devices beyond cardiac ablation into fields like oncology, pain management, and cosmetic surgery is broadening their user base and application areas, propelling market growth. Increased opportunities for professional training and education in ablation technology are enabling more medical professionals to become proficient in its use, expanding its implementation in clinical settings. Additionally, patient awareness and demand for minimally invasive treatments are contributing significantly to the growth of this market. Enhancements in device safety through technological advances and operator experience are increasing trust in these procedures among both patients and practitioners, encouraging broader use. As the market for energy-based ablation devices continues to evolve, it is shaped by a convergence of technological, economic, and clinical factors, making these devices increasingly central to modern medical practice.

Select Competitors (Total 37 Featured) -

• AngioDynamics Inc.
• AtriCure Inc.
• BIOLASE Inc.
• biolitec AG
• Biosense Webster, Inc.
• Boston Scientific Corporation
• EDAP TMS S.A.
• Ethicon Endo-Surgery Inc.
• Halyard Health Inc.
• InSightec® Ltd.
• Medtronic Inc.
• Monteris Medical Inc.
• Olympus America Inc.
• Photocure ASA
• PhotoMedex Inc.
• Sichuan Jinjiang Electronic Science and Technology Co. Ltd.
• Smith & Nephew Plc
• Stryker Corporation
• Syneron & Candela
• Varian Medical Systems

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.